These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 11575182
81. Quinolones in 2005: an update. Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM. Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423 [Abstract] [Full Text] [Related]
82. [How well do gyrase inhibitors work? The pharmacokinetics of quinolones]. Sörgel F, Bulitta J, Kinzig-Schippers M. Pharm Unserer Zeit; 2001 Apr; 30(5):418-27. PubMed ID: 11575179 [No Abstract] [Full Text] [Related]
83. [Quinolones in the environment: biological breakdown of gyrase inhibitors]. Wetzstein HG. Pharm Unserer Zeit; 2001 Apr; 30(5):450-7. PubMed ID: 11575183 [No Abstract] [Full Text] [Related]
84. [New quinolones]. Kakeya H, Fukushima K, Saito A. Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():542-8. PubMed ID: 17455678 [No Abstract] [Full Text] [Related]
85. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist]. Schurz JK. Pharm Unserer Zeit; 2001 Feb 28; 30(5):400-5. PubMed ID: 11575176 [No Abstract] [Full Text] [Related]
87. [Mechanisms of bacterial resistance to quinolones]. Taléns-Visconti R, Garrigues TM, Cantón E. Rev Esp Quimioter; 2002 Mar 28; 15(1):25-31. PubMed ID: 12582434 [Abstract] [Full Text] [Related]
88. Mechanisms of resistance to quinolones. Hirai K, Mitsuhashi S. Prog Drug Res; 1992 Mar 28; 38():107-20. PubMed ID: 1609109 [No Abstract] [Full Text] [Related]
92. Recent advances in structure activity relationships in new quinolones. Asahina Y, Ishizaki T, Suzue S. Prog Drug Res; 1992 Feb 28; 38():57-106. PubMed ID: 1609118 [No Abstract] [Full Text] [Related]
93. [New 4-quinolone derivatives in review]. Holzgrabe U, Heisig P. Pharm Unserer Zeit; 1999 Jan 28; 28(1):30-5. PubMed ID: 10078027 [No Abstract] [Full Text] [Related]
94. [Amidinohydrazones as subjects of drug research. 2]. Richter PH, Wunderlich I, Schleuder H, Keckeis A. Pharmazie; 1993 Mar 28; 48(3):163-84. PubMed ID: 8493282 [No Abstract] [Full Text] [Related]
95. Quinolones. Chambers ST. N Z Med J; 1995 Jul 14; 108(1003):273-7. PubMed ID: 7637926 [No Abstract] [Full Text] [Related]
96. [Where are quinolones going? New agents in development]. Holzgrabe U. Pharm Unserer Zeit; 2001 Jul 14; 30(5):446-8. PubMed ID: 11575182 [No Abstract] [Full Text] [Related]
97. Update on cross-resistance of fluoroquinolones. Garau J. Int J Clin Pract Suppl; 2000 Dec 14; (115):94-8. PubMed ID: 11219309 [No Abstract] [Full Text] [Related]
98. [Recent development in quinolone compounds antitumor quinolones]. Yang YS, Zhao SR, Ji RY, Chen KX. Yao Xue Xue Bao; 1998 Dec 14; 33(2):157-60. PubMed ID: 11938953 [No Abstract] [Full Text] [Related]
99. Mode of action of new quinolones: the inhibitory activity on DNA gyrase. Sato K, Hoshino K, Mitsuhashi S. Prog Drug Res; 1992 Dec 14; 38():121-32. PubMed ID: 1319080 [No Abstract] [Full Text] [Related]
100. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. Ruiz J. J Antimicrob Chemother; 2003 May 14; 51(5):1109-17. PubMed ID: 12697644 [Abstract] [Full Text] [Related] Page: [Previous] [New Search]